13OD

13OD: sourced facts only. name: "13-Oxyingenol-dodecanoate inhibits the growth of non-small cell lung cancer cells by targeting ULK1." [PMID:38626492]; target: "13-Oxyingenol-dodecanoate inhibits the growth of non-small cell lung cancer cells by targeting ULK1." [PMID:38626492]; developer: "Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Liaoning Province, Engineering Research Center of Natural Medicine Active Molecule Research & Development, Liaoning Province, Key Laboratory of Natural Bioactive Compounds Discovery & Modification, Shenyang, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China." [PMID:38626492]; stage: "The study found that 13OD effectively inhibited the cell proliferation and colony formation of NSCLC cells (A549 and H460 cells), with less toxicity in normal human lung epithelial BEAS-2B cells." [PMID:38626492]